During the past decade, Hualien Tzu Chi Hospital conducted 31 clinical trials. In the 10-year time frame, 31 clinical trials started and 4 clinical trials were completed, i.e. on average, 12.9% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 3 clinical trials were completed. i.e. 18.8% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Hualien Tzu Chi Hospital" #1 sponsor was "Buddhist Tzu Chi General Hospital" with 7 trials, followed by "Amgen" with 2 trials sponsored, "Janssen Research & Development, LLC" with 2 trials sponsored, "PharmaEssentia" with 2 trials sponsored and "Abbott Medical Devices" with 2 trials sponsored. Other sponsors include 14 different institutions and companies that sponsored additional 24 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hualien Tzu Chi Hospital" #1 collaborator was "Brightech International" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Buddhist Tzu Chi General Hospital" with 1 trials as a collaborator, "Chang Gung Memorial Hospital" with 1 trials as a collaborator and "China Medical University Hospital" with 1 trials as a collaborator. Other collaborators include 18 different institutions and companies that were collaborators in the rest 28 trials.

According to Clinical.Site data, the most researched conditions in "Hualien Tzu Chi Hospital" are "Arthritis, Psoriatic" (2 trials), "Parkinson Disease" (2 trials), "ALK+ Advanced NSCLC" (1 trials), "Acute Ischemic Stroke" (1 trials) and "Anaemia Associated With Chronic Kidney Disease" (1 trials). Many other conditions were trialed in "Hualien Tzu Chi Hospital" in a lesser frequency.

Most popular intervention types in "Hualien Tzu Chi Hospital" are "Drug" (19 trials), "Other" (5 trials), "Biological" (4 trials), "Device" (3 trials) and "Behavioral" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Guselkumab" (2 trials), "18F-fluorocholine" (1 trials), "18F-fluorocholine PET/CT" (1 trials) and "ADSCs" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hualien Tzu Chi Hospital" are 31 trials for "All" genders, 1 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "Hualien Tzu Chi Hospital". undefined are not yet recruiting, 11 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 14 completed trials in Hualien Tzu Chi Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hualien Tzu Chi Hospital, 4 "Phase 1" clinical trials were conducted, 4 "Phase 2" clinical trials and 15 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 7 trials that are defined as “Not Applicable".